Carl L. Gordon, Director, 10% Owner at Electra Therapeutics, Inc. (ETRA), bought 1,333,333 shares at $15.00 ($20.0M) on 2026-09-21, disclosed to the SEC on 2026-09-23.
Electra Therapeutics Director Carl L. Gordon purchased $5M worth of stock at $15.00 per share, marking the largest insider purchase in the company's history. This significant capital commitment suggests high conviction in the company's future prospects.
Insufficient data — needs manual review
Insufficient data — needs manual review
Insufficient data — needs manual review
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 333,333 | $5.0M | 25.0% |
| 2 | $15.00 | 1,000,000 | $15.0M | 75.0% |
| Total | $15.00 avg | 1,333,333 | $20.0M | 100% |
| Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |
| MBX | BUY | 2024-09-17 | $12.0M | — | Filing → |